公司概覽
業務類別 Drug Manufacturers - General
業務概覽 Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
公司地址 Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
電話號碼 +1 609 252-4621
傳真號碼 --
公司網頁 https://www.bms.com
員工數量 32500
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Phil Holzer Senior Vice President, Principal Accounting Officer and Controller -- 11/02/2026
Ms. Sandra Leung Executive Vice President and General Counsel 美元 1.15M 18/02/2025
Mr. David V. Elkins Executive Vice President and Chief Financial Officer 美元 1.12M 11/02/2026
Dr. Christopher S. Boerner, PhD Chairman of the Board and Chief Executive Officer 美元 1.54M 11/02/2026
Mr. Adam Lenkowsky Executive Vice President and Chief Commercialization Officer -- 11/02/2026
Dr. Cristian Massacesi, M.D. Executive Vice President, Chief Medical Officer and Head of Development -- 11/02/2026
Mr. Hiroshi Chris Shibutani, M.D. Executive Vice President and Chief Strategy Officer -- 11/02/2026
Mr. Benjamin J. Hickey, M.B.A. President, RayzeBio Organization -- 11/02/2026
Ms. Amanda Ahn Poole Executive Vice President and Chief People Officer -- 11/02/2026
Ms. Cari Gallman Executive Vice President, General Counsel and Chief Policy Officer -- 11/02/2026
Ms. Wendy Short Bartie Executive Vice President, Corporate Affairs -- 11/02/2026
Ms. Lynelle Hoch President, Cell Therapy Organization -- 11/02/2026
Ms. Karin Shanahan Executive Vice President, Chief Supply Chain and Operations 美元 1.01M 11/02/2026
Dr. Robert M. Plenge, M.D.,PhD Executive Vice President, Chief Research Officer and Head of Research -- 11/02/2026
Mr. Gregory Scott Meyers Executive Vice President, Chief Digital Officer and Chief Technology Officer -- 11/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Derica W. Rice Independent Director 11/02/2026
Ms. Phyllis R. Yale Independent Director 11/02/2026
Ms. Paula A. Price Independent Director 11/02/2026
Mr. Peter J. Arduini Independent Director 11/02/2026
Dr. Christopher S. Boerner, PhD Chairman of the Board and Chief Executive Officer 11/02/2026
Dr. Julia A. Haller, M.D. Independent Director 11/02/2026
Mr. Theodore R. Samuels Lead Independent Director 11/02/2026
Dr. Karen H. Vousden, PhD Independent Director 11/02/2026
Dr. Manuel Hidalgo Medina, M.D.,PhD Independent Director 11/02/2026
Mr. Michael R. McMullen Independent Director 11/02/2026
Dr. Deepak L. Bhatt, M.B.A.,M.D.,M.P.H. Independent Director 11/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:37)
代號 名稱 佔比% 持有日期
RECSColumbia Research Enhanced Core ETF0.04%04/02/2026
FELCFidelity Enhanced Large Cap Core ETF0.04%27/02/2026
DLNWisdomTree US LargeCap Dividend ETF0.03%27/02/2026
NULVNuveen ESG Large-Cap Value ETF0.03%27/02/2026
EVTEV Tax Advantaged Dividend Inc0.03%31/12/2025
VONGVanguard Russell 1000 Growth ETF0.03%31/01/2026
DFUSDimensional US Equity Market ETF0.03%27/02/2026
ACWIiShares MSCI ACWI ETF0.03%28/02/2026
FVDFirst Trust Value Line® Dividend ETF0.03%26/02/2026
JQUAJPMorgan US Quality Factor ETF0.03%27/02/2026
DHSWisdomTree US High Dividend ETF0.03%27/02/2026
IWViShares Russell 3000 ETF0.03%28/02/2026
TYTri-Continental Corporation0.03%31/01/2026
GSLCGoldman Sachs ActiveBeta® US LgCp Eq ETF0.03%27/02/2026
DFLVDimensional US Large Cap Value ETF0.02%27/02/2026
SDOGALPS Sector Dividend Dogs ETF0.02%28/02/2026
VOOVVanguard S&P 500 Value ETF0.02%31/01/2026
ESGVVanguard ESG US Stock ETF0.02%31/01/2026
EQWLInvesco S&P 100 Equal Weight ETF0.02%27/02/2026
IOOiShares Global 100 ETF0.02%28/02/2026
  1    2   3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18    19    20    21    22  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.